Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.42 |
| ▸ | NRP1 | O14786 | 2/20 | 0.42 |
| ▸ | NTSR2 | O95665 | 6/20 | 0.41 |
| ▸ | NTSR1 | P30989 | 6/20 | 0.41 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.41 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | GNRHR | P30968 | 1/20 | 0.40 |
| ▸ | NPY1R | P25929 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30423100 | 0.89 | APLNR (0.45) | APLNRNRP1NTSR2NTSR1NMUR2 | |
| SCHEMBL29391291 | 0.88 | GNRHR (0.47) | NTSR2NTSR1MMP1MMP3GNRHR | |
| SCHEMBL30440660 | 0.87 | OPRM1 (0.46) | NTSR2NTSR1NMUR2NMUR1 | |
| SCHEMBL30440639 | 0.81 | OPRM1 (0.47) | APLNRNMUR2NMUR1NPY1R | |
| SCHEMBL30440642 | 0.81 | OPRM1 (0.47) | APLNRNMUR2NMUR1NPY1R | |
| SCHEMBL29383471 | 0.81 | GNRHR (0.45) | APLNRNTSR2NTSR1GNRHR | |
| SCHEMBL29615168 | 0.81 | GNRHR (0.45) | APLNRNTSR2NTSR1GNRHR | |
| Acetic Acid SCHEMBL30440885 | 0.81 | OPRM1 (0.48) | APLNRNMUR2NMUR1 | |
| SCHEMBL29557983 | 0.79 | OPRM1 (0.49) | NTSR2NTSR1NMUR2NMUR1 | |
| SCHEMBL8773027 | 0.79 | APLNR (0.43) | APLNRNRP1NTSR2NTSR1NMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478708-A | Solid phase synthesis method of ganirelix fragment | 南京汉欣医药科技有限公司 | 2022-05-13 | — | — | CN | disclosed |